Cyclophotocoagulation during Boston keratoprosthesis eye surgery
Part of Eyes & vision clinical trials.
This trial looks at whether a specific eye laser treatment done through the white of the eye (called transscleral cyclophotocoagulation) works well and is safe for people getting a Boston keratoprosthesis. It may help improve comfort and vision outcomes for selected patients needing this type of cornea/eye replacement surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older).
- You can understand the study and sign informed consent.
- You are likely able to come to study visits and be followed during the study.
- You are a candidate for the Boston Keratoprosthesis type I.
- You have not joined another glaucoma drug or device treatment study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new laser device (ELIOS) during combined cataract and glaucoma surgery. It may help people who need both cataract removal and glaucoma treatment, aiming to lower eye pressure safely.
This trial tests a treatment called corneal collagen crosslinking to strengthen the tissue under a KPro type I (an artificial cornea). It may help reduce the risk of corneal melting in people who need a KPro.
This study tests an endoscopic laser procedure to lower eye pressure and slow damage in people with normal-tension glaucoma. It may help protect the optic nerve, especially if your glaucoma is stable on drops and you also have a cataract.
This study checks whether the Calibreye System can be used safely and effectively for people with certain types of glaucoma. It may help doctors better assess the eye before treatment, especially for selecting the right surgical approach.
This study tests a laser procedure guided by an eye scan to improve vision caused by surface (front) cornea cloudiness or irregularities. It may help some people whose vision problem is mainly in the outer cornea and can be safely treated without reaching deep tissue.
This trial tests whether injecting Humira (adalimumab) under the membrane of the eye can improve outcomes for people receiving a special type of artificial cornea called a Boston keratoprosthesis. It is for patients with severe corneal scarring and poor vision.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.